Related Experiment Videos
[Should elderly hypertensive patients be treated with a beta-blocker-diuretic combination?]
Zeitschrift Fur Gerontologie
|March 1, 1984
Summary
Viskaldix effectively lowered blood pressure in hypertensive seniors over 60 without adverse effects like bradycardia or orthostatic issues. This beta-blocker therapy is beneficial for elderly patients, especially those with coronary heart disease.
Area of Science:
- Geriatric Medicine
- Cardiology
- Pharmacology
Context:
- Hypertension is a prevalent condition in elderly individuals, increasing cardiovascular risk.
- Antihypertensive medications are crucial for managing blood pressure in older adults.
- Beta-blockers are commonly prescribed but require careful monitoring for side effects in the elderly.
Purpose:
- To evaluate the efficacy and safety of Viskaldix in hypertensive patients over 60 years.
- To assess the hypotensive effect and potential side effects of Viskaldix.
- To determine the impact of Viskaldix on metabolic parameters in elderly patients.
Summary:
- Viskaldix demonstrated an excellent hypotensive effect in both supine and standing positions in 30 hypertensive patients over 60.
- No instances of bradycardia or orthostatic dysregulation were observed during the 3-month treatment period.
- Metabolic parameters remained unaffected, which is a significant finding for geriatric care.
Impact:
- Viskaldix offers a safe and effective antihypertensive treatment option for elderly patients.
- The absence of metabolic disturbances makes Viskaldix particularly suitable for the aging population.
- This study highlights the potential benefits of beta-blocker therapy in elderly patients with underlying coronary heart disease.